Crossmark

Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer

Crossref DOI link: https://doi.org/10.1007/s12282-022-01364-y

Published Online: 2022-06-21

Published Print: 2022-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Mengdi

Chen, Weilin

Liu, Deyue

Chen, Weiguo

Shen, Kunwei

Wu, Jiayi

Zhu, Li http://orcid.org/0000-0002-9294-5727
License Information

Text and Data Mining valid from 2022-06-21

Version of Record valid from 2022-06-21
More Information

Article History

Received: 7 February 2022

Accepted: 20 April 2022

First Online: 21 June 2022

Declarations

:

: The authors have no relevant financial or non-financial interests to disclose.

: The authors have no relevant financial or non-financial interests to disclose.

: The authors have no relevant financial or non-financial interests to disclose.

Document is current

Any future updates will be listed below